期刊文献+

联合应用Survivin和VEGF反义寡核苷酸对肺癌A549细胞的抑制作用 被引量:2

Effect of antisense oligonucleotide targeting Survivin and VEGF on the inhibition of A549 cells
下载PDF
导出
摘要 目的研究非小细胞肺癌(non-small cell lung cancer,NSCLC)A549细胞经Survivin和VEGF反义寡核苷酸(ASODN)单独和联合转染后细胞生长、凋亡以及对基因表达的抑制作用。方法针对Survivin和VEGF mRNA序列设计反义寡核苷酸,以脂质体(Lip)为载体,介导Survivin和VEGF ASODN单独和联合转染A549细胞。MTT法检测细胞生长抑制率,RT-PCR检测细胞中Survivin和VEGF基因的mRNA含量,流式细胞术检测细胞凋亡以及细胞中Survivin基因的蛋白表达。结果经脂质体转染后200-600 nmol/L Survivin ASODN和5~20μmol/L VEGF ASODN均能抑制A549细胞增殖,诱导细胞凋亡;在48 h时,400 nmol/L Survivin ASODN和10μmol/L VEGF ASODN抑制率和凋亡率有统计学意义(P〈0.05);两者联合转染A549细胞抑制率和凋亡率分别为(61.37±1.94)%和57.03%,显著高于两基因单独转染(P〈0.05);联合组的Survivin mRNA的表达量为(15.26±1.31)%,蛋白表达率为(30.40±1.33)%,VEGF mRNA的表达量为(13.12±1.45)%,均显著低于单独转染组(P〈0.05)。结论 Survivin和VEGF ASODN均能抑制A549细胞基因表达,诱导细胞凋亡,两基因反义寡核苷酸联合转染的效果优于单独转染。 [Objective] To investigate cell growth, apoptosis and inhibition of gene expression after trans- fection Survivin antisense oligonueleotides (ASODN) alone or combined with VEGF ASODN on A549 cells. [Methods] We designed a human Survivin and VEGF antisense oligonueleotides. Survivin ASODN alone or combined with VEGF ASODN were transfected into A549 cells by Lipofectin. The MTT assay was used to detect the cell proliferation, mRNA expression of Survivin and VEGF were detected by reverse transcription- polymerase chain reaction (RT-PCR), the apoptotie rates and protein expression levels of the two genes were analyzed by flow eytometry (FCM). [Results] After transfected with Lipofectamine, 200- 600 nmol/L Survivin ASODN or 5 - 20 μmol/L VEGF ASODN could inhibited A549 cell proliferation and induced apoptosis; inhibition rate and apoptosis rate was significantly rise at 48 h after A549 cells transfected with 400 nmol/L Survivin ASODN or 10 μmol/L VEGF ASODN (P〈0.05); after transfected with 400 nmol/L Survivin and 10 μmol/ L VEGF ASODN, the inhibition rate was (61.37 ± 1.94)% and the apoptosis rate was 57.03%, significantly higher than the two genes transfected alone (P〈0.05); in the combined group Survivin mRNA and protein expression levels was (15.26 ±1.31)% and (30.40 ±1.33)%, VEGF mRNA expression was (13.12 ±1.45)%, which were obviously decreased than transfected alone (P 〈0.05). [Conclusion] Both Survivin and VEGF ASODN could inhibit the gene expression of A549 cells and induce the apoptosis. The efficiency of co-transfect was better than transfect alone.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第8期46-50,共5页 China Journal of Modern Medicine
关键词 存活蛋白 血管内皮生长因子 反义寡核苷酸 非小细胞肺癌 Survivin vascular endothelial growth factor antisense oligonucleotide non-small-cell lungcarcinoma
  • 相关文献

参考文献10

  • 1JEMAL A, SIEGEL R, WARD E, et al. Cancer statistics[J]. CA Cancer J Clin, 2007, 57(1): 43-66.
  • 2FARHAT FS, TFAYLI A, FAKHRUDDIN N, et al. Expression, prognostic and predictive impact of VEGF and Bfgf in non-small cell lung cancer[J]. Crit Rev Oncol Hematol, 2012, 84(2): 149- 160.
  • 3IKEHARA M, OSHITA F, KAMEDA Y, et al. Expression of Surviving correlated with vessel invasion is a marker of poor prognosis in small adeno carcinoma of the lung[J]. Oncol Rep, 2002, 9: 835-838.
  • 4VIVEK R, KANNAN S, ACHIRAMAN S. et al. Survivin defi- ciency leads to imparalization of cytokinesis in cancer cells[J]. Asian Pac J Cancer Prev, 2011, 12(7): 1675-1679.
  • 5ROSATO A, MENIN C, BOLDRIN D, et al. Survivin expression impacts prognostically on NSCLC but not SCLC[J]. Lung Cancer, 2013, 79(2): 180-186.
  • 6SONG JL, CAO LP, LI YX. RNA interference mediated inhibi- tion of survivin and VEGF in pancreatic cancer cells in vitro[J]. Mol Med Report, 2013, 7(5): 1651-1655. Chinese.
  • 7陈国超.Survivin和VEGF在胃癌组织中的表达及相关性研究[J].中国现代医生,2012,50(23):42-43. 被引量:5
  • 8陶琳,姚峰,李华,余峰,王敏,刘铭球.survivin基因表达与非小细胞肺癌发生发展的关系[J].中国肺癌杂志,2003,6(4):275-277. 被引量:12
  • 9TRAN J, MASTER Z, YU JL, et al. A role for survivin in the more sisitance of endothelial ceils mediated by VEGF[J]. Proc Natl Acad Sci USA, 2002, 99(7): 4349-4354.
  • 10王玲,李侠,李玉,薛玉文.Survivin、VEGF的表达及微血管密度与非小细胞肺癌临床病理特征的关系[J].癌症,2005,24(7):823-826. 被引量:15

二级参考文献29

  • 1黄莉,卿笃信.Survivin与VEGF在胃癌、胃黏膜不典型增生中的表达及相关性研究[J].胃肠病学和肝病学杂志,2006,15(5):451-455. 被引量:8
  • 2[7]Andrade F, Roy S, Nicholson D, et al. Granzyme B directly and efficiently cleaves several downstreem caspase substrates: implications for CTL-induced apoptosis. Immunity,1998,8(4)∶451-460.
  • 3[8]Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut,2000,46(5)∶645-650.
  • 4[10]Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol,1998,152(1)∶43-49.
  • 5[1]Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med,1997,3(8)∶917-921.
  • 6[2]Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest,1999,79(9)∶1121-1126.
  • 7[3]Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res,2000,6(1)∶127-134.
  • 8[5]Keer JFR, Winterford CM, Harman BV. Apoptosis, its significance in carcinoma and carcinoma therapy. Carcinoma,1994,73(3)∶2013-2017.
  • 9[6]LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene,1998,17(25)∶3247-3259.
  • 10Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expression in cancer and lymphoma [J]. Nat Med, 1997,3(8) :917-921.

共引文献28

同被引文献28

  • 1王英,张睢扬,钱桂生,王希良.RyR反义寡核苷酸对气道平滑肌细胞增殖及细胞内钙离子浓度的影响[J].中国应用生理学杂志,2005,21(3):324-328. 被引量:3
  • 2Holmseth S, Scott HA, Real K, et al. The concentrations and distributions of three C-terminal variants of the GLT-1 (EAAT2; slcla2) glutamate transporter protein in rat brain tissue suggest differential regulation [ J ]. Neurosci, 2009, 162(4) : 1055-1071.
  • 3Stephenson ML, Zamecnik PC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide [J]. Proc Natl Acad Sci USA, 1978, 75(1) : 285-288.
  • 4Kato H, Liu Y, Araki T, et al. Temporal profile of the ef- fects of pretreatment with brief cerebral ischemia on the neu- ronal damage following secondary ischenfic insult in the ger- bil: cumulative damage and protective effects [ J]. Brain Res, 1991, 553(2): 238-242.
  • 5Kitagawa K, Matsumoto M, Kuwabara K, et al. ' Ischemic tolerance' phenomenon detected in various brain regions[ J]. Brain Res, 1991, 561(2) : 203-211.
  • 6Dumont AO, Hetmans E, Goursaud S. Differential regulation of the glutamate transporter variants GLT-la and GLT-lb in the cortex and spinal cord of transgenic rats expressinghSODl(G93A) [J]. Neurochem Int, 2013, 63(2): 61-68.
  • 7Dttmont AO, Goursaud S, Desmet N, et a!. Differential reg- ulation of glutamate transporter subtypes by pro-inflammatory cytokine TNF-c in cortical astrocytes from a rat motel of amy- otrophic lateral sclerosis[J]. PLoS One, 2014, 9(5): e97649.
  • 8Meabon JS, Lee A, Meeker KD, et al. Differential expres- sion of the glutamate transporter GLT-1 in pancreas [ J ]. J H/stochem Cytochem, 2012, 60(2): 139-151.
  • 9Rothstein JD, Patel S, Regan MR, et al. Beta-lactam an- tibiotics offer neuroprotection by increasing glutamate trans- porter expression[J]. Nature, 2005, 433(7021): 73-77.
  • 10Liu YX, Zhang M, Liu LZ, et al. The role of glutamate transporter-la in the induction of brain ischemic tolerance in rats[J]. G//a, 2012, 60(1): 112-124.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部